About
Cube Labs is an Italian healthtech venture builder that spins out academic life-science research (via an exclusive partnership with INBB) into companies; listed on Euronext Growth Milan since 2023, it holds ~20 portfolio companies across biotech, medtech, e-health and R&D Tech/AI.
Capital graph
Founders / team· 3
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Cube Labs
Cube Labs is an Italian healthtech venture builder that spins out academic life-science research (via an exclusive partnership with INBB) into companies; listed on Euronext Growth Milan since 2023, it holds ~20 portfolio companies across biotech, medtech, e-health and R&D Tech/AI.
—
United States
BusinessLatest roundTotal raisedDate- Century Health
AI that processes clinical notes and electronic health data into research-ready real-world evidence datasets for pharma and life sciences companies
Seed · $7M · 2026-05
$7M - AcuityMD
Business intelligence and market data platform for medical device companies, helping them understand product utilization, physician adoption and market performance
Series C · $160M · 2026-04 · Valuation $955M
$160MValuation $955M - Vi
AI platform for patient engagement, care navigation, clinical workflows and operational decision-making for healthcare, life sciences and health organizations
Undisclosed · $145M · 2026-05
$145M
China
BusinessLatest roundTotal raisedDate- 中科欣扬
Synthetic biology platform built on extremophile microbial resources, developing bioactive ingredients for the pharmaceutical, food and cosmetics industries; commercialized products include ergothioneine, NMN and vanillin.
Series C · $42M · 2026-07
$42M - Kossel Medtech
R&D and manufacturing of pan-vascular interventional devices (peripheral intervention, coronary, electrophysiology, core raw materials), plus OEM/CDMO services for implantable devices
Series C · 2026-09
— - WiseDiag
Medical AI large models and AI health management services
Series A · $10M · 2026-05
$10M
Europe
BusinessLatest roundTotal raisedDate- L’école AI
Computer vision platform for healthcare and life sciences
Seed · $3M · 2023-10
$3M - Flinn.ai
Automates regulatory and quality workflows for medical device and pharmaceutical companies
Series A · $32M · 2026-02
$32M - IgniteData
Automatically transfers patient data from electronic health records to clinical trial electronic data capture systems
Seed · $8M · 2024-06
$8M
Other / unspecified
BusinessLatest roundTotal raisedDate- Halmos Labs
AI-driven automated R&D systems for biotech and pharma that simulate experimental outcomes before wet-lab work and recommend the experiments that most reduce uncertainty
— - Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - Gero
Biotech targeting aging and chronic disease
Series A · $6M · 2023-10
$6M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.